Facilitating diabetic retinopathy screening using automated retinal image analysis in underresourced settings.


Journal

Diabetic medicine : a journal of the British Diabetic Association
ISSN: 1464-5491
Titre abrégé: Diabet Med
Pays: England
ID NLM: 8500858

Informations de publication

Date de publication:
09 2021
Historique:
revised: 17 03 2021
received: 06 12 2020
accepted: 30 03 2021
pubmed: 8 4 2021
medline: 31 3 2022
entrez: 7 4 2021
Statut: ppublish

Résumé

To evaluate an automated retinal image analysis (ARIA) of indigenous retinal fundus images against a human grading comparator for the classification of diabetic retinopathy (DR) status. Indigenous Australian adults with type 2 diabetes (n = 410) from three remote and very remote primary-care services in the Northern Territory, Australia, underwent teleretinal DR screening. A single, central retinal fundus photograph (opportunistic mydriasis) for each eye was later regraded using a single ARIA and a UK human grader and national DR classification system. The sensitivity and specificity of ARIA were assessed relative to the comparator. Proportionate agreement and a Kappa statistic were also computed. Retinal images from 391 and 393 participants were gradable for 'Any DR' by the human grader and ARIA grader, respectively. 'Any DR' was detected by the human grader in 185 (47.3%) participants and by ARIA in 202 (48.6%) participants (agreement =88.0%, Kappa = 0.76,), whereas proliferative DR was detected in 31 (7.9%) and 37 (9.4%) participants (agreement = 98.2%, Kappa = 0.89,), respectively. The ARIA software had 91.4 (95% CI, 86.3-95.0) sensitivity and 85.0 (95% CI, 79.3-89.5) specificity for detecting 'Any DR' and 96.8 (95% CI, 83.3-99.9) sensitivity and 98.3 (95% CI, 96.4-99.4) specificity for detecting proliferative DR. This ARIA software has high sensitivity for detecting 'Any DR', hence could be used as a triage tool for human graders. High sensitivity was also found for detection of proliferative DR by ARIA. Future versions of this ARIA should include maculopathy and referable DR (CSME and/or PDR). Such ARIA software may benefit diabetes care in less-resourced regions.

Identifiants

pubmed: 33825229
doi: 10.1111/dme.14582
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e14582

Informations de copyright

© 2021 Diabetes UK.

Références

Lee R, Wong TY, Sabanayagam C. Epidemiology of diabetic retinopathy, diabetic macular edema and related vision loss. Eye Vis. 2015;2(1):17.
Association AD. Reduction in weight and cardiovascular disease risk factors in individuals with type 2 diabetes: one-year results of the look AHEAD trial. Diabetes Care. 2007;30(6):1374-1383.
Thomas R, Halim S, Gurudas S, Sivaprasad S, Owens D. IDF Diabetes Atlas: a review of studies utilising retinal photography on the global prevalence of diabetes related retinopathy between 2015 and 2018. Diabetes Res Clin Pract. 2019;157:107840.
Scanlon PH. The English national screening programme for diabetic retinopathy 2003-2016. Acta Diabetol. 2017;54(6):515-525.
Avidor D, Loewenstein A, Waisbourd M, Nutman A. Cost-effectiveness of diabetic retinopathy screening programs using telemedicine: a systematic review. Cost Eff Resour Alloc. 2020;18:1-9.
Bhaskaranand M, Ramachandra C, Bhat S, et al. The value of automated diabetic retinopathy screening with the EyeArt system: a study of more than 100,000 consecutive encounters from people with diabetes. Diabetes Technol Ther. 2019;21(11):635-643.
Rajalakshmi R, Subashini R, Anjana RM, Mohan V. Automated diabetic retinopathy detection in smartphone-based fundus photography using artificial intelligence. Eye. 2018;32(6):1138.
Scotland GS, McNamee P, Fleming AD, et al. Costs and consequences of automated algorithms versus manual grading for the detection of referable diabetic retinopathy. Br J Ophthalmol. 2010;94(6):712-719.
Bouhaimed M, Gibbins R, Owens D. Automated detection of diabetic retinopathy: results of a screening study. Diabetes Technol Ther. 2008;10(2):142-148.
Jelinek HJ, Cree MJ, Worsley D, Luckie A, Nixon P. An automated microaneurysm detector as a tool for identification of diabetic retinopathy in rural optometric practice. Clin Exp Optom. 2006;89(5):299-305.
Niemeijer M, van Ginneken B, Russell SR, Suttorp-Schulten MS, Abramoff MD. Automated detection and differentiation of drusen, exudates, and cotton-wool spots in digital color fundus photographs for diabetic retinopathy diagnosis. Invest Ophthalmol Vis Sci. 2007;48(5):2260-2267.
Philip S, Fleming AD, Goatman KA, et al. The efficacy of automated “disease/no disease” grading for diabetic retinopathy in a systematic screening programme. Br J Ophthalmol. 2007;91(11):1512-1517.
Welikala R, Dehmeshki J, Hoppe A, et al. Automated detection of proliferative diabetic retinopathy using a modified line operator and dual classification. Comput Methods Programs Biomed. 2014;114(3):247-261.
Fleming AD, Goatman KA, Philip S, et al. The role of haemorrhage and exudate detection in automated grading of diabetic retinopathy. Br J Ophthalmol. 2010;94(6):706-711.
Tufail A, Rudisill C, Egan C, et al. Automated diabetic retinopathy image assessment software: diagnostic accuracy and cost-effectiveness compared with human graders. Ophthalmology. 2017;124(3):343-351.
Fleming AD, Goatman KA, Philip S, Prescott GJ, Sharp PF, Olson JA. Automated grading for diabetic retinopathy: a large-scale audit using arbitration by clinical experts. Br J Ophthalmol. 2010;94(12):1606-1610.
Tufail A, Kapetanakis VV, Salas-Vega S, et al. An observational study to assess if automated diabetic retinopathy image assessment software can replace one or more steps of manual imaging grading and to determine their cost-effectiveness. Health Technol Assess. 2016;20(92):1-72.
Brazionis L, Jenkins A, Keech A, Ryan C, Bursell S-E. An evaluation of the telehealth facilitation of diabetes and cardiovascular care in remote Australian Indigenous communities:-protocol for the telehealth eye and associated medical services network [TEAMSnet] project, a pre-post study design. BMC Health Serv Res. 2017;17(1):1-12.
Statistics ABo. Australian Standard Geographical Classification (ASGC) 2006 [updated 27/09/2007. Available from: https://www.abs.gov.au/AUSSTATS/abs@.nsf/Latestproducts/1AEE5890BD5B7B5ECA2571A90017901F?opendocument.
Bourne RR, Flaxman SR, Braithwaite T, et al. Magnitude, temporal trends, and projections of the global prevalence of blindness and distance and near vision impairment: a systematic review and meta-analysis. Lancet Glob Health. 2017;5(9):e888-e897.
Brazionis L, Jenkins A, Keech A, et al. Diabetic retinopathy in a remote Indigenous primary healthcare population: a Central Australian diabetic retinopathy screening study in the Telehealth Eye and Associated Medical Services Network project. Diabet Med. 2018;35(5):630-639.
Wakerman J, Humphreys J, Russell D, et al. Remote health workforce turnover and retention: what are the policy and practice priorities? Hum Resour Health. 2019;17(1):1-8.
Al Turk L, Wang S, Krause P, et al. Evidence based prediction and progression monitoring on retinal images from three nations. Transl Vis Sci Technol. 20209(2):44.
Singer DE, Nathan DM, Fogel HA, Schachat AP. Screening for diabetic retinopathy. Ann Intern Med. 1992;116(8):660-671.
Mitchell P, Foran S, Wong T, et al. Guidelines for the management of diabetic retinopathy. National Health and Medical Research Council. 2008.
Sosale B, Aravind SR, Murthy H, et al. MSimple, mobile-based artificial intelligence algorithm in the detection of diabetic retinopathy (SMART) study. BMJ Open Diabetes Res Care. 2020;8(1).
Olson J, Sharp P, Goatman K, et al. Improving the economic value of photographic screening for optical coherence tomography-detectable macular oedema: a prospective, multicentre, UK study. Health Technol Assess. 2013;17(51).
Gulshan V, Peng L, Coram M, et al. Development and validation of a deep learning algorithm for detection of diabetic retinopathy in retinal fundus photographs. JAMA. 2016;316(22):2402-2410.
Ting DSW, Cheung CY-L, Lim G, et al. Development and validation of a deep learning system for diabetic retinopathy and related eye diseases using retinal images from multiethnic populations with diabetes. JAMA. 2017;318(22):2211-2223.
Abràmoff MD, Lavin PT, Birch M, Shah N, Folk JC. Pivotal trial of an autonomous AI-based diagnostic system for detection of diabetic retinopathy in primary care offices. NPJ Digit Med. 2018;1(1):1-8.

Auteurs

Nicola Quinn (N)

NHMRC Clinical Trials Centre, The University of Sydney, Sydney, NSW, Australia.
Centre for Public Health, Queen's University, Belfast, UK.

Laima Brazionis (L)

NHMRC Clinical Trials Centre, The University of Sydney, Sydney, NSW, Australia.
Department of Medicine, The University of Melbourne, Melbourne, VIC, Australia.

Benjamin Zhu (B)

NHMRC Clinical Trials Centre, The University of Sydney, Sydney, NSW, Australia.

Chris Ryan (C)

NHMRC Clinical Trials Centre, The University of Sydney, Sydney, NSW, Australia.
Department of Medicine, The University of Melbourne, Melbourne, VIC, Australia.

Rossella D'Aloisio (R)

Centre for Public Health, Queen's University, Belfast, UK.
Department of Medicine and Science of Ageing, Ophthalmology Clinic, University "G. d'Annunzio" Chieti-Pescara, Chieti, Italy.

Hongying Lilian Tang (H)

Department of Computer Science, University of Surrey, Guildford, UK.

Tunde Peto (T)

Centre for Public Health, Queen's University, Belfast, UK.

Alicia Jenkins (A)

NHMRC Clinical Trials Centre, The University of Sydney, Sydney, NSW, Australia.
Centre for Public Health, Queen's University, Belfast, UK.
Department of Medicine, The University of Melbourne, Melbourne, VIC, Australia.
NHMRC Clinical Trials Centre, The University of Sydney, Sydney, NSW, Australia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH